Table 2. Follow up histology results for women with at least one follow up test by mRNA test result. at baseline.
mRNA test at baseline | ||||||||
Follow up results | Negative | Positive | Invalid | Total | ||||
N (row%) (col%) | N (row%) (col%) | N (row%) (col%) | N (row%) (col%) | |||||
Total | 250 (72.1) (100) | 82 (23.6) (100) | 15 (4.3) (100) | 347 (100) (100) | ||||
No biopsy | 206 | 63 | 11 | 280 | ||||
(82.4) | (76.8) | (73.4) | (80.7) | |||||
CIN1 | 42 | 16 | 2 | 60 | ||||
(16.8) | (19.5) | (13.3) | (17.3) | |||||
CIN2+ | 2 | 3 | 2 | 7 | ||||
(0.8) | (3.7) | (13.3) | (2.0) | |||||
Absolute risk * | 3.7 | 18.4 | 57.5 | 6.7 | ||||
95%CI | 0.4–13 | 4–53 | 7–192 | 2–16 |
CIN2+/1,000 person/years.